the consensus is generally moving towards the need for a biphasic pharmacological approach for treatment. The first phase of the disease (from the onset of the symptoms up to 7–10 days) is characterized by viral-induced cytopathic effects,...
Long COVID has been associated with a broad range of symptoms and health impacts5,7,8,9. A previous study showed that symptoms of long COVID, although commonly observed among patients with other viral infections such as influenza, occur more frequently following infection with SARS-CoV-210. Se...
(Dong et al., 2020). COVID Control1is another Johns Hopkins dashboard that usesvolunteered geographic information(Goodchild, 2007) for syndromic surveillance of COVID-19 related symptoms at the county level in the U.S. Additional examples of COVID-19 dashboards include the World Health ...
(2021) found that although around 40% of children experienced an increase in stress and anxiety, roughly 10% of the sample displayed a decrease in these symptoms. Additionally, Yarger and colleagues (2021) documented a decrease in depressive symptoms for autistic children upon commencement of lock...
Table 1 Results from logistic regression of the response to the question “How much, if at all, do the symptoms you have had in the last 7 days reduce your/their ability to carry out day-to-day activities?” as a function of BA.2 / BA.1 infection, age group, sex, booster vaccine...
Somatic symptoms were more likely among college students expressing greater concern regarding the threat to life and health posed by COVID-19, and the efficacy of prevention and control measures. Among primary school students, only the concern for life and health was associated with a higher ...
1994;7(2):257–73. Article CAS PubMed Google Scholar Venkatesh A, Edirappuli S. Social distancing in covid-19: what are the mental health implications? BMJ. 2020;369. Tso IF, Park S. Alarming levels of psychiatric symptoms and the role of loneliness during the COVID-19 epidemic: a...
Effect of Oral Azithromycin vs Placebo on COVID-19 Symptoms in Outpatients With SARS-CoV-2 Infection JAMA Original Investigation August 10, 2021 This randomized trial assesses the effect of a single dose of azithromycin vs placebo on absence of COVID-19 symptoms at posttreatment day 14 among ou...
Participants with long-lasting COVID-19 symptoms were excluded after their 30th day of reporting loss of smell and/or taste to ensure that the estimates were not inflated due to post-acute sequelae of COVID-19. As in Step 1, we (a) excluded symptoms reported during the first 7 days ...
6,7 Long COVID, also referred to as ongoing symptomatic COVID-19 and post-acute sequelae of COVID-19 (PASC), is defined as symptoms of COVID-19 that persist for between 4 and 12 weeks or a post-acute syndrome at over 12 weeks after the onset of acute symptoms that cannot be ...